Ascites in cirrhosis.
作者信息
Spital A
出版信息
Ann Intern Med. 1987 Jan;106(1):169-70. doi: 10.7326/0003-4819-106-1-169_2.
PMID:3789569
Abstract
摘要
相似文献
1
Ascites in cirrhosis.肝硬化腹水
Ann Intern Med. 1987 Jan;106(1):169-70. doi: 10.7326/0003-4819-106-1-169_2.
2
3
Spironolactone and metabolic acidosis.螺内酯与代谢性酸中毒。
Ann Intern Med. 1979 Aug;91(2):321-2. doi: 10.7326/0003-4819-91-2-321_3.
4
Hyperkalemic intermittent paralysis associated with spironolactone in a patient with cardiac cirrhosis.一名心源性肝硬化患者中与螺内酯相关的高钾性间歇性麻痹。
Am Heart J. 1968 Sep;76(3):393-8. doi: 10.1016/0002-8703(68)90236-6.
5
[Diuretic treatment of hepatic cirrhosis: use of distal diuretics].[肝硬化的利尿治疗：远端利尿剂的应用]
Rev Clin Esp. 1974 Jan 15;132(1):65-70.
6
[Treatment of ascites in hepatic cirrhosis].[肝硬化腹水的治疗]
Rev Esp Enferm Apar Dig. 1966 Nov;25(9):1021-46.
7
[Treatment of resistant ascites in cirrhotic patients].[肝硬化患者难治性腹水的治疗]
Union Med Can. 1974 Dec;103(12):2081-9.
8
[Effects of triamterene in combination with other diuretics in liver cirrhosis].氨苯蝶啶与其他利尿剂联合应用于肝硬化的效果
Minerva Med. 1963 Oct 10;54(81 Suppl):3018-23.
9
[Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].[螺内酯和坎利酸钾治疗腹水型肝硬化的效果。双盲研究]
Minerva Dietol Gastroenterol. 1984 Jul-Sep;30(3):255-61.
10
Spironolactone and canrenoate: different antialdosteronic diuretic agents.螺内酯和坎利酸钾：不同的抗醛固酮利尿剂。
Hepatology. 1991 May;13(5):999-1000.
Zotero 插件